Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Aspiriant

Aspiriant Defensive Allocation Fund (RMDFX)

Ticker RMDFX · Since 2015-12-14 · · Holdings as of Jun 30, 2026

Expense ratio
5.35%$535/yr per $10k
5-yr return
+5.8%annualized
1-yr return
+18.8%as of Dec 2025
Net assets
$1.1Ball share classes
Holdings
15

Bottom line

Is RMDFX a good fund? The bottom line

RMDFX is a managed allocation / balanced mutual fund from Aspiriant.

Its expense ratio is 5.35% — about $535 a year on every $10,000 invested, more expensive than 100% of allocation / balanced funds we track.

It returned +18.8% over one year, +5.8% a year over five years, +5.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.1 billion in net assets and 15 holdings, its largest position is GMO Benchmark-Free Allocation Fund (26.4%) and the top 10 make up 86.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (5.35%)
  • Concentrated: top 10 holdings are 86.5% of assets

Updated Nov 19, 2026

What RMDFX invests in

The Aspiriant Defensive Allocation Fund (the Fund or Defensive Allocation Fund) seeks to achieve long-term investment returns with lower risk and lower volatility than the stock market, and with relatively low correlation to stock and bond market indexes.

The Defensive Allocation Fund is a fund-of-funds that seeks to provide an investment return that has lower volatility than traditional asset classes (i.e., public equity and investment grade bonds) by combining several non-traditional or alternative asset class exposures, including investments that focus on a specialized asset class such as long-short strategies. Non-traditional or alternative asset classes have tended over time to have a lower correlation with the broad U.S. stock and bond markets. The Fund allocates its assets among a variety of non-traditional or alternative asset classes listed below so as to capture diversifying returns from these non-traditional or alternative sources. The Defensive Allocation Fund invests primarily in Underlying Funds and may, to a limited extent, invest in separately managed accounts (SMAs), which are private portfolios of securities for…

From the fund's prospectus (filed Jul 29, 2026).

RMDFX performance

Fund calendar-year total returns, 2016–2025 2016: +1.4%; 2017: +9.4%; 2018: −4.9%; 2019: +11.5%; 2020: +5.1%; 2021: +4.2%; 2022: −6.8%; 2023: +8.0%; 2024: +6.2%; 2025: +18.8% +1% 2016 +9% 2017 −5% 2018 +12% 2019 +5% 2020 +4% 2021 −7% 2022 +8% 2023 +6% 2024 +19% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
RMDFX+18.8%+5.8%+5.0%
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full RMDFX performance history →

What RMDFX costs

On a $10,000 investment, RMDFX's 5.35% expense ratio costs about $535 a year. The prospectus estimates $5,311 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full RMDFX fee table →

RMDFX top 10 holdings

#Holding% of fund
1GMO Benchmark-Free Allocation Fund26.36%
2Wilshire Bridgewater Managed Alpha (Ireland) Fund12.15%
3iShares Gold Trust7.38%
4Victory Pioneer Multi-Asset Income Fund7.33%
5Lazard Global Investment Funds plc - Lazard Rathmore Alternative Fund7.02%
6Millennium International Ltd.6.43%
7Eaton Vance Global Macro Absolute Return Advantage Fund6.26%
8GMO Investments ICAV - GMO Equity Dislocation Investment Fund5.63%
9Elliott Associates LP4.31%
10State Street Bridgewater All Weather ETF3.64%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 86.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to RMDFX

More funds like RMDFX →

RMDFX FAQ

What is the expense ratio of RMDFX?
RMDFX's expense ratio is 5.35%, which works out to about $535 a year for every $10,000 invested. The prospectus estimates total costs of $5,311 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RMDFX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (5.35%); concentrated: top 10 holdings are 86.5% of assets. This is general information, not personalized advice.
What does RMDFX hold?
RMDFX's largest holdings are GMO Benchmark-Free Allocation Fund (26.4%), Wilshire Bridgewater Managed Alpha (Ireland) Fund (12.1%), iShares Gold Trust (7.4%), Victory Pioneer Multi-Asset Income Fund (7.3%), Lazard Global Investment Funds plc - Lazard Rathmore Alternative Fund (7.0%). It holds 15 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RMDFX's 5-year return?
RMDFX returned +5.8% a year over the five years ending Dec 31, 2025, and +5.0% a year over ten years. Past performance does not guarantee future results.
Does RMDFX have a sales load?
No. RMDFX has no front-end sales charge.
Who manages RMDFX?
RMDFX is offered by Aspiriant through Aspiriant Trust.